Cytovene (ganciclovir) / Roche |
ChiCTR-ONRC-11001232: Phase II study of Recombinant Adenovirus-Herpes Simplex Virus Thymidine Kinase (ADV-TK) combined with Ganciclovir in recurrent head and neck cancer of late-stage |
|
|
| Completed | 2 | 41 | | Recombinant Adenovirus-Herpes Simplex Virus Thymidine Kinase (ADV-TK) combined with Ganciclovir | Shenzhen Tiandakang Gene Engineering Co., Ltd.,; Wuhan Tiandakang Biotech Engineering Co., Ltd., Shenzhen Tiandakang Gene Engineering Co., Ltd. | Head and neck cancer in late-stage | | | | |
ChiCTR-ONRC-11001233: Phase II study of Recombinant Adenovirus-Herpes Simplex Virus Thymidine Kinase (ADV-TK) combined with Ganciclovir in primary hepatocellular carcinoma |
|
|
| Completed | 2 | 43 | | Recombinant Adenovirus-Herpes Simplex Virus Thymidine Kinase (ADV-TK) combined with Ganciclovir | Shenzhen Tiandakang Gene Engineering Co., Ltd.; Wuhan Tiandakang Bio-Tech Engineering Co., Ltd., Shenzhen Tiandakang Gene Engineering Co., Ltd. | Primary hepatocellular carcinoma in late stage | | | | |
2011-001449-34: Study for the treatment of cytomegalovirus infection, in transplanted patients Estudio para el tratamiento de la infeccion por citomegalovirus, en pacientes trasplantados. |
|
|
| Ongoing | 2 | 64 | Europe | GANCICLOVIR, FOSCARNET, VALGANCICLOVIR, CYMEVENE, FOSCAVIR, VALCYTE, CYMEVENE, FOSCAVIR, VALCYTE | FUNDACION INVESTIGACION HOSPITAL CLINICO DE VALENCIA-INSTITUTO DE INVESTIGACION SANITARIA INCLIVA, Ministerio de Sanidad y Politica Social | Cytomegalovirus infection in patients treated with hematopoietic allogenic transplant INFECCION POR CITOMEGALOVIRUS EN PACIENTES TRATADOS CON TRASPLANTE HEMATOPOYETICO ALOGENICO | | | | |
2011-002603-15: Study for the treatment of cytomegalovirus infection in critically ill patients on mechanical ventilation Estudio del tratamiento de la infeccion por citomegalovirus en pacientes criticos con ventilacion mecanica. |
|
|
| Ongoing | 2 | 42 | Europe | CYMEVENE, CYMEVENE, CYMEVENE | FUNDACION INVESTIGACION HOSPITAL CLINICO DE VALENCIA-INSTITUTO DE INVESTIGACION SANITARIA INCLIVA, Ministerio de Sanidad y Politica Social | Active infection with cytomegalovirus (CMV) in critically ill patients on mechanical ventilation with severe sepsis or septic shock Infección activa por el citomegalovirus (CMV) en el paciente crítico en ventilación mecánica con sepsis grave o shock séptico | | | | |
2017-002912-15: Secondary prophylaxis after CMV disease in kidney transplants targeted by γδ T cells monitoring. Prophylaxie secondaire ciblée par l’immunosurveillance des lymphocytes T γδ après infection à CMV. |
|
|
| Not yet recruiting | 2 | 37 | Europe | valganciclovir, Tablet, Injection, Rovalcyte, Cymevan | CHU de Bordeaux, CHU de Bordeaux | Kidney transplants patients Patients greffés rénaux, Kidney transplants patients Patients greffés rénaux, Diseases [C] - Virus Diseases [C02] | | | | |
2020-005197-10: Nanatinostat and Valganciclovir in R/R EBV+ Lymphoma (“NAVAL-1”) |
|
|
| Not yet recruiting | 2 | 150 | Europe | Nanatinostat, Valganciclovir, ganciclovir, VRx-3996, Film-coated tablet, Powder for concentrate for solution for infusion, Valganciclovir hydrochloride | Viracta Therapeutics, Inc., Viracta Therapeutics, Inc. | Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas, Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas, Diseases [C] - Cancer [C04] | | | | |
NCT06474442: A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis |
|
|
| Not yet recruiting | 2 | 40 | RoW | BD111 Injection (investigational new drug), BD111 Lentivirus-like particles, also called HSV-1-erasing lentiviral particles (HELP), Triple-drugs therapy of HSV-1 stromal keratitis, Ganciclovir Eye gel+Valacilovir Tablets+Prednisolone Acetate Eye Drops | Shanghai BDgene Co., Ltd. | Herpes Simplex Virus Type I Stromal Keratitis | 12/25 | 12/26 | | |
| Recruiting | 2 | 23 | US | CMV Cytotoxic T-Lymphocytes, CTLs, Anti-viral Therapy, valganciclovir, ganciclovir | New York Medical College | Congenital Cytomegaloviral (CMV) Disease | 10/27 | 10/28 | | |